Plain-English translation of NCT05600374 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called repetitive transcranial magnetic stimulation (rTMS)—a non-invasive brain stimulation technique—to help people recover arm and hand movement after an ischemic stroke. The key innovation is that the stimulation is timed to sync with your brain's natural electrical rhythms, specifically targeting moments when your motor brain is most responsive. Researchers want to see if this personalized timing approach works better than standard stimulation or sham (fake) treatment.
After a stroke, many people struggle with arm and hand weakness that can last for months or years, even with physical therapy. This trial exists because animal and early human studies suggest that brain stimulation timed to match the brain's natural oscillations might enhance the brain's ability to rewire itself and recover lost movement—but this hasn't been rigorously tested in stroke patients yet.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be randomly assigned to one of three groups. Over 5 consecutive weekdays, you'll receive 20 minutes of magnetic brain stimulation to your motor cortex (the part of your brain that controls movement), either timed to your brain waves or not, or a sham version. After each stimulation session, you'll do 40 minutes of focused physical therapy for your arm and hand. The trial team will monitor your progress with standard stroke recovery tests over the following weeks and months.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
Germany